13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • NORTH

    Acronym: 

    NORTH

    ACTRN/NCT /ethics: 

    Scientific title: 

    A phase II study study of panobinostat in paediatric, adolescent and young adult patients with solid tumours including osteosarcoma, malignant rhaboidntumour/ atypical teratoid rhabdoid tumours and neuroblastoma.

    Summary of trial and patient characteristics

    Cancer Type Other
    Trial Type Treatment
    Phase Phase II Tumour Stream Osteosarcoma
    Age Range 18 years and older Cancer Stage All stages
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Other
    Trial Type Treatment
    Phase Phase II
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Osteosarcoma
    Cancer Stage All stages
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Lay Summary

    A phase II study study of panobinostat in paediatric, adolescent and young adult patients with solid tumours including osteosarcoma, malignant rhaboidntumour/ atypical teratoid rhabdoid tumours and neuroblastoma.

    Sponsor / Cooperative group

    ANZCHOG

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Royal Adelaide Hospital Anne Milton anne.milton@sa.gov.au 08 7074 2342 Nimit Singhal Recruiting